Ignite Creation Date:
2024-05-06 @ 7:27 PM
Last Modification Date:
2024-10-26 @ 3:06 PM
Study NCT ID:
NCT06011772
Status:
RECRUITING
Last Update Posted:
2024-05-03
First Post:
2023-08-21
Brief Title:
EGF-Depleting Therapy CIMAvax-EGF in Combination With Standard Therapy for RAS- and BRAF Wild-Type Metastatic Colorectal Cancer
Sponsor:
Roswell Park Cancer Institute
Organization:
Roswell Park Cancer Institute
Organization Data
Organization:
Roswell Park Cancer Institute
Class:
OTHER
Study ID:
I 1578122
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Roswell Park Cancer Institute
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None